Mercanto Holdings Inc.
Mercanto Holdings Inc. operates in cannabis and wellness industries in Canada and the United States. It engages in the production and sale of cannabis-based products and beverages. The company was formerly known as The Good Shroom Co Inc. and changed its name to Mercanto Holdings Inc. in February 2025. Mercanto Holdings Inc. is headquartered in Québec, Canada.
Mercanto Holdings Inc. (TGSHF) - Net Assets
Latest net assets as of October 2025: $103.95K USD
Based on the latest financial reports, Mercanto Holdings Inc. (TGSHF) has net assets worth $103.95K USD as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.04 Million) and total liabilities ($939.56K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $103.95K |
| % of Total Assets | 9.96% |
| Annual Growth Rate | -39.48% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 35.21 |
Mercanto Holdings Inc. - Net Assets Trend (2021–2025)
This chart illustrates how Mercanto Holdings Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mercanto Holdings Inc. (2021–2025)
The table below shows the annual net assets of Mercanto Holdings Inc. from 2021 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-07-31 | $242.01K | -58.50% |
| 2024-07-31 | $583.10K | +27.43% |
| 2023-07-31 | $457.57K | -40.01% |
| 2022-07-31 | $762.81K | -57.73% |
| 2021-07-31 | $1.80 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mercanto Holdings Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 245281400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $13.41 Million | 5540.92% |
| Total Equity | $242.01K | 100.00% |
Mercanto Holdings Inc. Competitors by Market Cap
The table below lists competitors of Mercanto Holdings Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Syntholene Energy Corp.
V:ESAF
|
$1.77 Million |
|
Caspar
WAR:CSR
|
$1.77 Million |
|
Wellnex Life Ltd
AU:WNX
|
$1.77 Million |
|
Ignite Ltd
AU:IGN
|
$1.77 Million |
|
Oberstdorfer Bergbahn AG
MU:KVO
|
$1.77 Million |
|
Desert Metals Ltd
AU:DM1
|
$1.77 Million |
|
Omnia Metals Group Ltd
AU:OM1
|
$1.77 Million |
|
Hamat Group Ltd
TA:HAMAT
|
$1.77 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mercanto Holdings Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 583,097 to 242,010, a change of -341,087 (-58.5%).
- Net loss of 412,313 reduced equity.
- Other factors increased equity by 71,226.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-412.31K | -170.37% |
| Other Changes | $71.23K | +29.43% |
| Total Change | $- | -58.50% |
Book Value vs Market Value Analysis
This analysis compares Mercanto Holdings Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.81x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 3.84x to 12.81x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-07-31 | $0.02 | $0.06 | x |
| 2023-07-31 | $0.01 | $0.06 | x |
| 2024-07-31 | $0.01 | $0.06 | x |
| 2025-07-31 | $0.00 | $0.06 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mercanto Holdings Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -170.37%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -13.76%
- • Asset Turnover: 2.94x
- • Equity Multiplier: 4.22x
- Recent ROE (-170.37%) is below the historical average (-137.82%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -213.34% | -1589.86% | 0.11x | 1.27x | $-4.03 Million |
| 2022 | -213.55% | -134.06% | 0.74x | 2.16x | $-1.71 Million |
| 2023 | -98.81% | -14.29% | 2.19x | 3.16x | $-497.90K |
| 2024 | 6.96% | 1.04% | 2.63x | 2.54x | $-17.71K |
| 2025 | -170.37% | -13.76% | 2.94x | 4.22x | $-436.51K |
Industry Comparison
This section compares Mercanto Holdings Inc.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mercanto Holdings Inc. (TGSHF) | $103.95K | -213.34% | 9.04x | $1.77 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |